Xbrane Biopharma AB (XBRANE) — Tangible Net Worth Ratio
Xbrane Biopharma AB (XBRANE) has a Tangible Net Worth Ratio of 44.5% as of March 2026. This metric is calculated by deducting intangible assets (Skr305.08 Million) from net assets (Skr550.16 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See XBRANE book value for net asset value and shareholders' equity analysis.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Xbrane Biopharma AB Tangible Net Worth Ratio (2012–2025)
This chart shows how Xbrane Biopharma AB's Tangible Net Worth Ratio has changed across 14 annual periods from 2012 to 2025. As of March 2026, the ratio stands at 44.5%, reflecting net assets of Skr550.16 Million with intangible assets of Skr305.08 Million SEK. Also explore XBRANE shareholders equity momentum to track the company's year-over-year net asset growth rate.
Annual Tangible Net Worth Ratio for Xbrane Biopharma AB (2012–2025)
The table below presents the year-by-year Tangible Net Worth Ratio for Xbrane Biopharma AB from 2012 to 2025, covering 14 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see XBRANE stock market capitalisation.
| Year | Tangible NW Ratio | Net Assets (SEK) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 47.1% | Skr560.65 Million | Skr296.46 Million | Skr671.62 Million | ▲ +27.5 pp |
| 2024 | 19.6% | Skr208.54 Million | Skr167.69 Million | Skr842.43 Million | ▼ -22.2 pp |
| 2023 | 41.8% | Skr171.34 Million | Skr99.67 Million | Skr653.51 Million | ▼ -34.2 pp |
| 2022 | 76.0% | Skr424.89 Million | Skr102.00 Million | Skr690.51 Million | ▼ -12.5 pp |
| 2021 | 88.5% | Skr431.74 Million | Skr49.67 Million | Skr688.43 Million | ▼ -9.9 pp |
| 2020 | 98.4% | Skr257.71 Million | Skr4.08 Million | Skr463.76 Million | ▲ +1.2 pp |
| 2019 | 97.3% | Skr184.32 Million | Skr5.05 Million | Skr338.94 Million | ▲ +4.2 pp |
| 2018 | 93.1% | Skr83.07 Million | Skr5.77 Million | Skr252.88 Million | ▲ +0.2 pp |
| 2017 | 92.9% | Skr88.41 Million | Skr6.30 Million | Skr110.96 Million | ▲ +0.8 pp |
| 2016 | 92.1% | Skr107.30 Million | Skr8.46 Million | Skr118.11 Million | ▲ +4.8 pp |
| 2015 | 87.3% | Skr47.51 Million | Skr6.03 Million | Skr75.33 Million | ▼ -12.7 pp |
| 2014 | 100.0% | Skr6.30 Million | Skr0.00 | Skr6.69 Million | ▲ +0.0 pp |
| 2013 | 100.0% | Skr8.69 Million | Skr0.00 | Skr9.20 Million | ▲ +0.0 pp |
| 2012 | 100.0% | Skr88.11K | Skr0.00 | Skr657.01K | — |